Analyzing...
Loading company...
Apollo Hospitals Enterprise Ltd. engages in the operation and management of hospitals, diagnostic centers and pharmacies. The company is headquartered in Chennai, Tamil Nadu and currently employs 83,147 full-time employees. The firm is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. The firm's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The company is engaged in hospitals and hospitals-based services. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast moving consumer goods and private label products business from various services using the digital platform. The firm has approximately 10,000 beds across 71 hospitals, 6000 pharmacies and 200 clinics and diagnostic centers, as well as 150 telemedicine centers.
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹25,228 Cr service revenue.
Employee costs at 11.9% of revenue — primary cost driver.
“Apollo twenty four seven target of achieving breakeven by end of this fiscal remains...We are on course. There might be one hiccup...but we are on course”
“I think we are quite confident that we will get back into 30%...Bangladesh, at least 60% has started coming back in October”
“Healthcare services EBITDA was at 781 crores, registering a growth of 8% year on year, and health care services margin remained robust to 24.6”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 20.5%▲ | 9.0% |
| ROCE | 19.5%▲ | 10.4% |
| Net Margin | 7.6%▼ | 8.5% |
| EBITDA Margin | 15.5%▼ | 20.6% |
| Debt To Equity | 0.60x▲ | 0.16x |
| Rev Growth 3yr | 15.0%▲ | 14.4% |
| EPS Growth 3yr | 33.3%▲ | 9.9% |
| Employee Cost Ratio | 11.90x | - |
Historical valuation data not available.
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹25,229 Cr +15.8% | ₹21,794 Cr +14.3% | ₹19,059 Cr +14.7% | ₹16,612 Cr +13.3% | ₹14,663 Cr +38.9% | ₹10,560 Cr -6.1% | ₹11,247 Cr +16.9% | ₹9,617 Cr |
| Other Income | ₹192 Cr -4.3% | ₹200 Cr +88.4% | ₹106 Cr +17.7% | ₹90 Cr +15.6% | ₹78 Cr +73.7% | ₹45 Cr +66.8% | ₹27 Cr -14.2% | ₹31 Cr |
| Total Income | ₹25,420 Cr +15.6% | ₹21,994 Cr +14.8% | ₹19,166 Cr +14.7% | ₹16,703 Cr +13.3% | ₹14,741 Cr +39.0% | ₹10,605 Cr -5.9% | ₹11,274 Cr +16.8% | ₹9,649 Cr |
| COGS | ₹13,076 Cr +15.6% | ₹11,310 Cr +15.3% | ₹9,806 Cr +14.4% | ₹8,574 Cr +13.2% | ₹7,573 Cr +33.2% | ₹5,684 Cr +3.4% | ₹5,499 Cr +18.0% | ₹4,661 Cr |
| ₹22,785 Cr +14.0% | ₹19,988 Cr +12.3% | ₹17,805 Cr +14.4% | ₹15,559 Cr +15.6% | ₹13,457 Cr +28.8% | ₹10,445 Cr -3.4% | ₹10,812 Cr +16.6% | ₹9,276 Cr | |
| Profit Before Tax | ₹2,616 Cr +30.4% | ₹2,006 Cr +47.2% | ₹1,363 Cr +19.1% | ₹1,144 Cr -27.5% | ₹1,578 Cr +615.0% | ₹221 Cr -66.6% | ₹660 Cr +77.2% | ₹373 Cr |
| Exceptional Items | (₹19 Cr) | ₹0.00 Cr -100.0% | ₹2 Cr | ₹0.00 Cr -100.0% | ₹294 Cr +384.9% | ₹61 Cr -69.4% | ₹198 Cr | ₹0.00 Cr |
| ₹658 Cr +23.3% | ₹534 Cr +19.9% | ₹446 Cr +73.9% | ₹256 Cr -46.3% | ₹477 Cr +463.2% | ₹85 Cr -62.4% | ₹225 Cr +29.9% | ₹173 Cr | |
| Net Profit | ₹2,003 Cr +33.1% | ₹1,505 Cr +61.0% | ₹935 Cr +10.7% | ₹845 Cr -23.8% | ₹1,108 Cr +710.4% | ₹137 Cr -68.3% | ₹432 Cr +115.7% | ₹200 Cr |
| Profit (Owners) | ₹1,942 Cr +34.3% | ₹1,446 Cr +60.9% | ₹899 Cr +9.7% | ₹819 Cr -22.4% | ₹1,056 Cr +602.1% | ₹150 Cr -66.9% | ₹455 Cr +92.7% | ₹236 Cr |
| Minority Interest | ₹61 Cr +3.0% | ₹59 Cr +62.6% | ₹36 Cr +42.7% | ₹26 Cr -51.7% | ₹53 Cr ↑ Recovery | (₹14 Cr) +41.2% | (₹23 Cr) +35.5% | (₹36 Cr) |
| Other Comprehensive Income | ₹58 Cr ↑ Recovery | (₹6 Cr) +39.4% | (₹10 Cr) +21.6% | (₹13 Cr) -36.5% | (₹10 Cr) ↓ Decline | ₹15 Cr ↑ Recovery | (₹0.60 Cr) +97.9% | (₹29 Cr) |
| EPS | ₹135.03 | ₹100.56 | ₹62.50 | ₹56.97 | ₹73.42 | ₹10.46 | ₹32.70 | ₹16.97 |
| Diluted Shares | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
| Profit Or Loss Of Associates | ₹45 Cr +36.1% | ₹33 Cr +83.3% | ₹18 Cr ↑ Recovery | (₹43 Cr) ↓ Decline | ₹7 Cr +854.5% | ₹0.77 Cr ↑ Recovery | (₹3 Cr) ↓ Decline | ₹0.98 Cr |
Apollo Hospitals Enterprise Limited has informed the Exchange about Schedule of meet
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement - Additional information in relation to the scheme
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Resignation of Mr DINESH MADHAVAN as Other of the company w.e.f. May 30, 2026.
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement
Apollo Hospitals Enterprise Limited has informed the Exchange about Transcript
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates - Update on Board Meeting
Apollo Hospitals Enterprise Limited has informed the Exchange about Credit Rating- New
Apollo Hospitals Enterprise Limited has informed the Exchange about Schedule of meet
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Transcript